One mechanism through which RBM15::MKL1 induces leukemia in vitro and in vivo is through aberrant binding and activation of RBPJ, which is essential for the differentiation bias toward megakaryocytes and proliferation of leukemic cells (Mercher et al., 2009). This evidence concerns the gene MRTFA and leukemia.